Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;14(3):1009-1016.
doi: 10.4103/jfmpc.jfmpc_1335_24. Epub 2025 Mar 25.

A longitudinal study depicting persistence of COVID-19 antibodies after half a year using chemiluminescent microparticle immunoassay among healthcare workers and frontline workers in Mumbai, India's largest metropoli

Affiliations

A longitudinal study depicting persistence of COVID-19 antibodies after half a year using chemiluminescent microparticle immunoassay among healthcare workers and frontline workers in Mumbai, India's largest metropoli

Rujuta S Hadaye et al. J Family Med Prim Care. 2025 Mar.

Abstract

Introduction: Antibodies play a role in herd immunity, and studies estimate that COVID-19 antibody protection lasts approximately 1 to 4 months following COVID-19 vaccination and 6 to 8 months following infection. As healthcare workers and frontline workers were highly exposed to the infection, it is necessary to know if they have developed immunity against COVID-19.

Aim: To estimate the seroprevalence of SARS-CoV-2 antibodies among health care workers and frontline workers in Mumbai qualitatively and quantitatively and observe the change in antibody levels after 6 months.

Material and methods: This longitudinal study was conducted over 9 months in two phases among 1544 healthcare workers (HCWs) and 1555 frontline workers (FLWs) aged above 18 years in Mumbai, Maharashtra, India. Participants' blood samples were analyzed using the SARS-CoV-2 IgG-II Quant assay for the qualitative and quantitative determination of IgG antibodies to SARS-CoV-2. A follow-up was done after 6 months.

Results: A total of 2733 (88.2%) of the 3099 participants were followed up in Phase II, which included 1370 (50.1%) FLWs and 1363 (49.9%) HCWs. The study found a seropositivity rate of 99.9% with a significantly higher antibody titre in BEST (public transport) workers, those vaccinated with precautionary doses, those vaccinated with precautionary doses with a history of confirmed COVID-19 disease, and participants over 45 years.

Conclusions: The study findings indicate a widespread seroconversion against COVID-19 and a beneficial effect of precautionary dose in addition to two doses of the COVID-19 vaccine. The role of subclinical infection needs to be explored.

Keywords: COVID-19; India; Mumbai; immunity; serosurvey.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Map of the study site showing Mumbai district in the state of Maharashtra, India [Source: Modi S. Econ in the Bar. 2018 Feb 28. Internet. Available from: medium.com/econinthebar]
Figure 2
Figure 2
Flowchart of methodology [Source: Original]
Figure 3
Figure 3
Correlation between duration from last vaccine dose and antibody titer at follow-up (Phase II) [Source: Original]

Similar articles

References

    1. World Health Organization. Coronavirus (COVID-19) Dashboard. [Last accessed on 2023 Dec 17]. Available from:https://covid19.who.int .
    1. World Bank. Population, total-India- Data. [Last accessed on 2023 Jan 17]. Available from:https://data.worldbank.org/indicator/SP. POP. TOTL?locations=IN .
    1. Government of India. India: MyGov.in; 2023. [[cited 2025 Jan 22]]. #IndiaFightsCorona COVID-19 archive [Internet] Available from:https://www.mygov.in/covid-19-archive .
    1. Ministry of Health and Family Welfare. CoWIN dashboard- Total vaccination doses- Mumbai. Available from:https://dashboard.cowin.gov.in/
    1. World Health Organization. Coronavirus disease (COVID-19): Serology, antibodies and immunity. [Last accessed on 2025 Jan 22]. Available from:https://www.who.int/newsroom/questions-and-answers/item/coronavirus-dise... .

LinkOut - more resources